SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028092
Filing Date
2018-11-07
Accepted
2018-11-07 16:49:47
Documents
61
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arpo-10q_20180930.htm 10-Q 1204796
2 EX-31.1 arpo-ex311_6.htm EX-31.1 20053
3 EX-31.2 arpo-ex312_9.htm EX-31.2 21267
4 EX-32.1 arpo-ex321_8.htm EX-32.1 10541
5 EX-32.2 arpo-ex322_7.htm EX-32.2 11746
  Complete submission text file 0001564590-18-028092.txt   4905851

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arpo-20180930.xml EX-101.INS 1055857
7 XBRL TAXONOMY EXTENSION SCHEMA arpo-20180930.xsd EX-101.SCH 37302
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arpo-20180930_cal.xml EX-101.CAL 30005
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arpo-20180930_def.xml EX-101.DEF 106666
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arpo-20180930_lab.xml EX-101.LAB 292278
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arpo-20180930_pre.xml EX-101.PRE 235705
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38560 | Film No.: 181167026
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1